Finland· FI-REL-REL63083
Comirnaty JN.1
A covid-19, rna-based vaccine product containing bretovameran, registered in Finland by BioNTech Manufacturing GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Covid-19, rna-based vaccine is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BN01 (covid-19, rna-based vaccine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Covid-19, rna-based vaccine · ATC J07BN01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Bretovameran
- Manufacturer
- BioNTech Manufacturing GmbH
- Country
- Finland (FI)
- ATC code
- J07BN01
- ATC class
- Covid-19, RNA-based vaccine
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Covid-19, rna-based vaccine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsComirnaty JN.1 10 microgram/dosis, concentraat voor dispersie voor injectieBioNTech Manufacturing GmbH
- CzechiaCOMIRNATY JN.1BioNTech Manufacturing GmbH, Mainz
- SwedenComirnaty JN.1 (10 doser) 3 mikrogram/dos Koncentrat till injektionsvätska, dispersionBioNTech Manufacturing GmbH
- IrelandCOMIRNATY JN.1 10 micrograms/dose concentrate for dispersion for injection children 5 to 11 yearsBioNTech Manufacturing GmbH
- FranceCOMIRNATY JN.1 10 microgrammes/dose, dispersion injectable. Vaccin à ARNm contre la COVID-19BIONTECH MANUFACTURING (ALLEMAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Comirnaty Jn.1
- Liechtenstein · Comirnaty Jn.1
- Norway · Comirnaty Jn.1
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e48e021d-6821-4610-aafb-172dedc4f5d1 GET /v1/drugs/e48e021d-6821-4610-aafb-172dedc4f5d1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, dispersio",
"route": "Lihakseen",
"ddd_unit": null,
"strength": "10 mikrog/annos",
"atc_label": "COVID-19-rokotteet, RNA-pohjaiset",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/20/1528/032-033",
"fimea_rel_id": "REL63083",
"authorised_at": "2024-07-08"
}See everything about covid-19, rna-based vaccine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.